Improving the estimation of the global burden of antimicrobial resistant infections
Limmathurotsakul D, Dunachie S, Fukuda K, Feasey NA, Okeke IN, Holmes AH, Moore CE, Dolecek C, van Doorn HR, Shetty N, Lopez AD, Peacock SJ
16 August, 2019
This paper illustrates limitations of current methods to estimate the global mortality from antimicrobial resistance (AMR). Two lead attempts have been made by the O’Neill review and the GBD 2016 study. This paper demonstrates that a direct comparison of these estimates is not possible due to the different methodological approaches, data sources and type of infections considered. To guide implementation of action plans and efficient resource allocation, it is crucial to capture deaths caused by AMR. This paper explores guiding principles and potential approaches for improving AMR estimates in the future.
Who this is for
- Policy makers
- Healthcare providers
- International public and private organizations
- Non-governmental organizations
- Current methods are limited: the counterfactual approach is hard to measure and understand while the ICD principle does not count most hospital-acquired AMR infections and an unknown proportion of community-acquired AMR infection as cause of death.
- There is a need to strengthen health systems to collect, analyse and share better quality data
- Improved methodological approaches to estimate deaths from AMR are needed. New methods need to be robust, reliable, sustainable and plausible.
Share this publication
Apply to become a member
Are you working in AMR surveillance and epidemiology? Join SEDRIC today to start communicating and collaborating with our community of experts.Apply to become a member